Trial Profile
Efficacy and Safety of Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteogenesis imperfecta
- Focus Adverse reactions
- Sponsors Novartis
- 14 Apr 2014 New trial record